We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ACARIX.ST

Price
0.26
Stock movement up
+0.01 (1.92%)
Company name
Acarix A/S
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Devices
Markedsværdi
281.89M
Ent værdi
247.20M
Pris/omsætning
49.65
Pris/bog
4.40
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-29.00%
1 års afkast
-19.21%
3 års afkast
-31.91%
5 års afkast
-16.58%
10 års afkast
-
Senest opdateret: 2025-06-22

UDBYTTE

ACARIX.ST betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning49.65
Pris til egenkapital4.40
EV i forhold til salg43.54

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier1.06B
EPS (TTM)-0.07
FCF pr. aktie (TTM)-0.07

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)5.68M
Bruttofortjeneste (TTM)5.13M
Driftsindkomst (TTM)-72.06M
Nettoindkomst (TTM)-72.23M
EPS (TTM)-0.07
EPS (1 år frem)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)90.31%
Driftsmargin (TTM)-1269.28%
Fortjenstmargin (TTM)-1272.31%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter44.18M
Nettotilgodehavender3.40M
Omsætningsaktiver i alt62.79M
Goodwill0.00
Immaterielle aktiver10.25M
Ejendomme, anlæg og udstyr510.00K
Sum aktiver73.55M
Kreditor5.12M
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser9.49M
Sum gæld9.49M
Aktionærernes egenkapital64.06M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)-69.49M
Investeringsudgifter (TTM)741.00K
Fri pengestrøm (TTM)-70.23M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-112.75%
Afkast af aktiver-98.20%
Afkast af investeret kapital-112.75%
Kontant afkast af investeret kapital-109.63%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning0.26
Daglig høj0.28
Daglig lav0.26
Daglig volumen844K
Højeste gennem alle tider8.29
1 års analytiker estimat0.45
Beta1.48
EPS (TTM)-0.07
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation-

Nedsidepotensial

Loading...
Nedsidepotensial-data
ACARIX.STS&P500
Nuværende prisfald fra top notering-96.86%-2.53%
Højeste prisfald-97.86%-56.47%
Højeste efterår dato21 Dec 20239 Mar 2009
Gennemsnitlig fald fra toppen-79.93%-11.04%
Gennemsnitlig tid til nyt højdepunkt428 days12 days
Maks. tid til nyt højdepunkt2135 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
ACARIX.ST (Acarix A/S) company logo
Markedsværdi
281.89M
Markedsværdi kategori
Small-cap
Beskrivelse
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Personale
14
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Sweden
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics – Open demonstrating that the CADScor® System is a cost-e...
26. juni 2025
Acarix, a global leader in AI and acoustics-based cardiac diagnostics, has been awarded the 2025 Digital Innovation Award with an honorable mention for Innovation in Cardiac Imaging at the Global Card...
14. marts 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues to demonstrate exceptional progress in its pursuit of o...
13. februar 2025
Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic partnership with Geo-Med, LLC, a renowned Service-Disabled Vete...
5. februar 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® Sy...
4. november 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-b...
22. august 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured companies' health plans. As healthcare ...
12. august 2024
VANCOUVER, BC / ACCESSWIRE / July 30, 2024 / Acarix CEO Aamir Mahmood joined Steve Darling from Proactive to share news the company has begun trading on the OTCQB Market in the United States, under th...
30. juli 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on the OTCQB Market in the US. Acarix´s shares wi...
15. juli 2024